References
- Egan KM, Nabors LB, Olson JJ, et al (2012). Rare TP53 genetic variant associated with glioma risk and outcome. J Med Genet, 49, 420-1. https://doi.org/10.1136/jmedgenet-2012-100941
- Enciso-Mora V, Hosking FJ, Di Stefano AL, et al (2013). Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222. Br J Cancer, 108, 2178-85. https://doi.org/10.1038/bjc.2013.155
- Guan X, Wang LE, Liu Z, et al (2013). Association between a rare novel TP53 variant (rs78378222) and melanoma, squamous cell carcinoma of head and neck and lung cancer susceptibility in non-Hispanic Whites. J Cell Mol Med, 17, 873-8. https://doi.org/10.1111/jcmm.12076
- Li Y, Gordon MW, Xu-Monette ZY, et al (2013). Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program. Blood, 121, 4529-40. https://doi.org/10.1182/blood-2012-12-471722
- Stacey SN, Sulem P, Jonasdottir A, et al (2011). A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet, 43, 1098-103. https://doi.org/10.1038/ng.926
- Zhou L, Yuan Q, Yang M (2012). A functional germline variant in the P53 polyadenylation signal and risk of esophageal squamous cell carcinoma. Gene, 506, 295-7. https://doi.org/10.1016/j.gene.2012.07.007
Cited by
- No Evidence of Association of the Arg72Pro p53 Gene Polymorphism with Cancer Risk in the Saudi Population: a Meta-Analysis vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5663
- rs78378222 polymorphism in the 3′-untranslated region of TP53 contributes to development of age-associated cataracts by modifying microRNA-125b-induced apoptosis of lens epithelial cells vol.14, pp.3, 2016, https://doi.org/10.3892/mmr.2016.5465